Thank you for publicly responding. It is refreshing despite the questionable usefullness of the statements. Still, I think many appreciate it. I suspect that this IS the meeting place for the majority of shareholders of MWW, therefore it IS an effective way to communicate with them in the public domain.
Sir, I think you would be hard-pressed to find anyone on this board who WANTS the company to fail (save perhaps a few). However, many of these posters, who are also shareholders, are upset having watched their capital disappear, and their ownership diluted. They put complete faith in management, and certainly not the fundamental value of the company. It is clear that the plan did not play out as anticipated, and I believe the vast majority do not hold management accountable for unforeseen delays. I think many would like to support both financially and pyschologically the revitalization of the company, but it is becoming increasingly difficult to understand the true state of affairs. Many just want to know where MWW stands right now. The analogy you provided is appreciated mostly because it is the first time I can think of when you have publicly represented the true condition of the patient(MWW).
I can't be sure if you were referring to an actual "meathead" post, or to my post considering I prompted you, but I can safely say that the questions I posed are in fact REAL. And I also do not see any venomous, or baseless accusations represented there.
I will restate them in more direct form:
1. Does MWW have on-going contracts with the companies listed in the Chairman's letter of April 2012? Or have some of them been cancelled, as reflected in the edited statement in the Mazda release? Can you provide an updated client roster if that is the case? My assumption is you can, considering the companies are advertised on the website.
2. As it stands, what is the fully diuted O/S? It is obviously impossible to value a company's shares (for those professionals of which you speak) without knowing an updated share structure (nevermind a revenue number). 475M is clearly not relevant.
3. Could you please update year-end revenue/profitability guidance taking into consideration the delays that MWW has experienced? Is $4M still a goal, or has it been reduced?
4. Can you explain how the super-preferreds are considered compensation as deemed in the relevent 8-K? (this one admittedly seems more accusatory in nature, but my original assumption remains intact; that it is all legal. Note I've also stated it was probably a crucial step for surviving, I just don't understand the guise upon which it was done so simply looking for an explanation of the compensation component if you can provide one.)
5. Is there a plan in place to retire some of the outstanding convertible notes? If so, how many, and when? This would provide a benchmark upon which to measure (for those professionals you speak of)
6. Is there sufficient capital in place to begin production once any outstanding contracts are given the green light, or will the company need to generate additional funds?
Obviously everyone understands the safe harbor nature of any answers you elect to provide.
If I was shot, I'd put much more faith in the surgeon who told it to me straight, rather than the casual doctor who tells me it's all going to be fine, don't worry about it.
If you choose not to (understandable), perhaps someone/a few will call and ask these same questions, then share. I still have faith the company can pull through, but I'm (probably not alone) not ready to throw more money into a black-hole of misinformation. Just give it to me straight...numbers and dates, no more analogies.
Thank you kindly, and best of luck.
I don't think you should punish the board, and your fellow shareholders for your feud with one poster.
AI
